KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Other Non Operating Income (2016 - 2026)

Pacific Biosciences Of California has reported Other Non Operating Income over the past 16 years, most recently at $2.8 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 114.04% year-over-year to $2.8 million; the TTM value through Dec 2025 reached $14.8 million, changed N/A, while the annual FY2025 figure was $14.8 million, N/A changed from the prior year.
  • Other Non Operating Income for Q4 2025 was $2.8 million at Pacific Biosciences Of California, down from $3.0 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $7.6 million in Q4 2022 and troughed at -$19.7 million in Q4 2024.
  • A 5-year average of $1.7 million and a median of $2.8 million in 2025 define the central range for Other Non Operating Income.
  • Biggest five-year swings in Other Non Operating Income: skyrocketed 8402.17% in 2022 and later plummeted 1069.9% in 2024.
  • Year by year, Other Non Operating Income stood at -$92000.0 in 2021, then skyrocketed by 8402.17% to $7.6 million in 2022, then tumbled by 73.38% to $2.0 million in 2023, then plummeted by 1069.9% to -$19.7 million in 2024, then skyrocketed by 114.04% to $2.8 million in 2025.
  • Business Quant data shows Other Non Operating Income for PACB at $2.8 million in Q4 2025, $3.0 million in Q3 2025, and $4.7 million in Q2 2025.